Skip to main content

Impact of COVID-19 Health Policies on Other Infectious Diseases

Call for Papers

During theEarth with a mask last year, world governments have implemented a variety of health policies aimed to contain the COVID-19 pandemic and gain time until vaccines and specific antiviral treatments become available. Stringent lockdowns, travel bans, physical distancing, mask usage, massive decentralized testing, and the requirement of special hygiene measures for the general population are among these interventions. Even with these policies in play, health systems overload and the economic burden caused by the pandemic have brought reduced and unequal access to health care worldwide.


In support of the UN’s Sustainable Development Goal 3, Good Health and Well-being, BMC Infectious Diseases is delighted to announce the release of Impact of COVID-19 Health Policies on Other Infectious Diseases. This collection aims to bring together original research articles and systematic reviews characterizing the benefits and detriments of COVID-19 pandemic health policies on prevention, transmission, diagnosis, and treatment of the whole spectrum of infectious diseases. Unsolicited narrative reviews will not be considered, as per the journal's policies.

­‍‍SDG3 eight hands making a circle together




Submission guidelines

Before submitting your manuscript, please ensure you have carefully read the submission guidelines for BMC Infectious Diseases. Please ensure you highlight in your cover letter that you are submitting to a collection and select the collection in the submission questionnaire in Editorial Manager. Please make sure you submit in Editorial Manager and not our new editorial submission system. 

Data sets and descriptions relevant to the collection will be considered in BMC Research Notes as Data Notes. You can find out more about this article type here. This type of content will be published in BMC Research Notes and included in the final collection.

­‍‍Accepted manuscripts will be added to the collection as and when they are published. 

Please email any pre-submission inquiries, request additional information, or if you’d like to get involved by emailing.

Submission from 1st July 2021 to June 30th, 2022.

Meet the Guest Editors

Professor Carlo Torti. Department of Medical and Surgical Sciences. University “Magna Graecia”, Italy

Dr. Torti is New Content ItemProfessor of Infectious Diseases at the University “Magna Graecia” (Italy) and Director of the Unit of Infectious and Tropical Diseases (COVID-19 Centre) at “Mater Domini” Teaching Hospital (Catanzaro, Italy). He is the author of more than 250 papers with a focus on diagnosis and treatment of viral infections. He is one of the Senior Editors for BMC Infectious Diseases.


Professor Elijah Paintsil.  Department of Pediatrics. Yale School of Medicine. USA

Dr. PaiNew Content Itemntsil is Professor of Pediatrics, of Pharmacology, of Epidemiology and of Management at Yale University and Chief of the Section of Pediatric Infectious Diseases & Global Health, Department of Pediatrics at Yale School of Medicine and the Program Director of Pediatric Infectious Diseases Fellowship Training Program and co-Director of the Yale Partnerships for Global Health. He is a member of the American Academy of Pediatrics, Society for Pediatric Research, and Academic Pediatric Society and a consultant to Africa CDC. His research interests are: Effects of antiretroviral therapy (ART) on mitochondrial biology and pediatric HIV treatment outcomes in resource-limited settings. Dr. Paintsil has been an Editorial Board Member for BMC Infectious Diseases since 2015.

Professor Peter Subirakwenda Nyasulu. Faculty of Medicine and Health Sciences. Stellenbosch University, South Africa

DrNew Content ItemNyasulu, PhD MScMed MACE, is Professor of Epidemiology at Stellenbosch University, Faculty of Medicine and Health Sciences. He is a Member of the American College of Epidemiology and an Honorary Associate Professor of Epidemiology at the School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa. Prof Suwirakwenda Nyasulu has extensive experience in epidemiological and clinical research in infectious diseases including HIV/AIDS, tuberculosis, pneumococcal diseases among others. He is also actively involved in the COVID-19 research response initiative of the Stellenbosch University, Faculty of Medicine & Health Sciences

There are currently no articles in this collection.